Retoradin Tablet 4 mg (Irsogladine Maleate)
Irsogladine Maleate 4mg
Tablet · Prescription medication
AhnGuk New Pharm Co., Ltd.
MFDS item code 201900599 · Approved 2019.01.23
This product's status changed to Expired on 2024.01.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastric ulcers and improvement of gastric mucosal lesions (erosions, bleeding, etc.) in gastritis
This medication is used to improve gastric mucosal lesions such as erosion, bleeding, redness, and swelling that occur during the exacerbation of acute gastritis and chronic gastritis, along with the treatment of gastric ulcers. Thus, it helps protect the gastric mucosa and alleviate symptoms.
Use as follows for each condition. The dose may be adjusted appropriately according to symptoms. 1) Gastric ulcer (Adults) Administer 4mg of irsogladine maleate orally once daily. 2) Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis (Adults) Administer 4mg of irsogladine maleate orally in 1 to 2 divided doses daily.
This medication contains lactose, so it should not be taken by individuals with a genetic disorder that prevents proper digestion of lactose. Taking this medication may cause liver function abnormalities, and symptoms such as elevated liver enzyme levels, constipation, skin rash, itching, and diarrhea may occur. Rarely, symptoms such as dizziness, drowsiness, abdominal distention, decreased appetite, and dry mouth may arise, so caution is advised. Elderly patients may have decreased physical function, so they should start at a lower dose and observe their condition while taking it. Women who are pregnant or may become pregnant should take this medication only if the benefits are judged to outweigh the risks, as its safety during pregnancy is not certain. Breastfeeding women should avoid taking this medication if possible, as it may pass into breast milk; if necessary, it is advisable to stop breastfeeding. The safety of this medication in children has not been sufficiently established, and there is limited experience in use, so it should be used cautiously. This medication should be stored out of reach of children, and it is safer and better for quality to keep it in its original container without transferring it to another.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air or moisture. It is advisable to maintain storage temperatures between 1 to 30 degrees Celsius.
White round tablet
30 tablets per bottle, 100 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Irsogladine Maleate 4mg
Tablet · Prescription medication
AhnGuk New Pharm Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 4mg
Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Orally disintegrating Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Dong-gu Bio Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Ilyun Pharmaceutical Co., Ltd.

Irsogladine Maleate 4mg
Tablet · Prescription medication
(Co., Ltd.) Nexpharm Korea
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.